Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Suppramote, Orawan
13  Ergebnisse:
Personensuche X
?
1

Corrigendum: Combining the SMAC mimetic LCL161 with Gemcita..:

Prasopporn, Sunisa ; Suppramote, Orawan ; Ponvilawan, Ben...
Frontiers in Oncology.  12 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

The Acquired Vulnerability Caused by CDK4/6 Inhibition Prom..:

Suppramote, Orawan ; Prasopporn, Sunisa ; Aroonpruksakul, Satinee...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

Combining the SMAC mimetic LCL161 with Gemcitabine plus Cis..:

Prasopporn, Sunisa ; Suppramote, Orawan ; Ponvilawan, Ben...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Dependency of Cholangiocarcinoma on Cyclin D–Dependent Kina..:

Sittithumcharee, Gunya ; Suppramote, Orawan ; Vaeteewoottacharn, Kulthida...
Hepatology.  70 (2019)  5 - p. 1614-1630 , 2019
Link: https://doi.org/10.1002/..
 
?
5

Combining the SMAC mimetic LCL161 with Gemcitabine plus Cis..:

Prasopporn, Sunisa ; Suppramote, Orawan ; Ponvilawan, Ben...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748615/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

The Acquired Vulnerability Caused by CDK4/6 Inhibition Prom..:

Suppramote, Orawan ; Prasopporn, Sunisa ; Aroonpruksakul, Satinee...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157389/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

DataSheet_1_Combining the SMAC mimetic LCL161 with Gemcitab..:

Sunisa Prasopporn ; Orawan Suppramote ; Ben Ponvilawan...
doi:10.3389/fonc.2022.1021632.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
8

The Acquired Vulnerability Caused by CDK4/6 Inhibition Prom..:

Orawan Suppramote ; Sunisa Prasopporn ; Satinee Aroonpruksakul...
https://www.frontiersin.org/articles/10.3389/fonc.2022.877194/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
9

DataSheet_1_The Acquired Vulnerability Caused by CDK4/6 Inh..:

Orawan Suppramote ; Sunisa Prasopporn ; Satinee Aroonpruksakul...
doi:10.3389/fonc.2022.877194.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
10

Combining the SMAC mimetic LCL161 with Gemcitabine plus Cis..:

Sunisa Prasopporn ; Orawan Suppramote ; Ben Ponvilawan...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1021632/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
11

DataSheet_1_Combining the SMAC mimetic LCL161 with Gemcitab..:

Sunisa Prasopporn ; Orawan Suppramote ; Ben Ponvilawan...
doi:10.3389/fonc.2022.1021632.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
12

DataSheet_2_The Acquired Vulnerability Caused by CDK4/6 Inh..:

Orawan Suppramote ; Sunisa Prasopporn ; Satinee Aroonpruksakul...
doi:10.3389/fonc.2022.877194.s002.  , 2022
Link: https://doi.org/10.3389/..
 
?
13

DataSheet_1_Combining the SMAC mimetic LCL161 with Gemcitab..:

Sunisa Prasopporn (12553843) ; Orawan Suppramote (12553840) ; Ben Ponvilawan (6420329)...
https://figshare.com/articles/dataset/DataSheet_1_Combining_the_SMAC_mimetic_LCL161_with_Gemcitabine_plus_Cisplatin_therapy_inhibits_and_prevents_the_emergence_of_multidrug_resistance_in_cholangiocarcinoma_pdf/21829023.  , 2023
Link: https://doi.org/10.3389/..
 
1-13